BIM 23056

BIM 23056 behaves as a potent and selective antagonist of somatostatin receptor 5.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
BIM 23056(CAS 150155-61-6)

CAT No: R0827

CAS No:150155-61-6

Synonyms/Alias:150155-61-6;BIM 23056;D-Alaninamide, D-phenylalanyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-phenylalanyl-3-(2-naphthalenyl)-;(2S)-6-Amino-N-[(2S)-1-[[(2S)-1-[[(2R)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanamide;FFYWKVFA;D-Phe-Phe-Tyr-D-Trp-Lys-Val-Phe-D-Nal-NH2;CHEMBL410596;SCHEMBL12912367;BDBM82256;BIM23056;AKOS024456811;DA-61666;DC-25-20;PD079144;CAS_150155-61-6;G12888;(2S)-6-AMINO-2-[(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-AMINO-3-PHENYLPROPANAMIDO]-3-PHENYLPROPANAMIDO]-3-(4-HYDROXYPHENYL)PROPANAMIDO]-3-(1H-INDOL-3-YL)PROPANAMIDO]-N-[(1S)-1-{[(1S)-1-{[(1R)-1-CARBAMOYL-2-(NAPHTHALEN-2-YL)ETHYL]CARBAMOYL}-2-PHENYLETHYL]CARBAMOYL}-2-METHYLPROPYL]HEXANAMIDE;D-Alaninamide,D-phenylalanyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-phenylalanyl-3-(2-naphthalenyl)-;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C71H81N11O9
M.W/Mr.
1232.5
Sequence
One Letter Code:FFYWKVFX
Three Letter Code:H-D-Phe-Phe-Tyr-D-Trp-Lys-Val-Phe-D-2Nal-NH2
Labeling Target
Somatostatin receptor 5 (sst5)
Appearance
White lyophilised solid
Purity
>98 %
Activity
Antagonist
Source#
Synthetic
Solubility
-20 °C
InChI
InChI=1S/C71H81N11O9/c1-44(2)63(71(91)81-61(39-47-22-10-5-11-23-47)67(87)77-58(64(74)84)41-49-29-32-50-24-12-13-25-51(50)36-49)82-66(86)57(28-16-17-35-72)76-70(90)62(42-52-43-75-56-27-15-14-26-54(52)56)80-69(89)60(40-48-30-33-53(83)34-31-48)79-68(88)59(38-46-20-8-4-9-21-46)78-65(85)55(73)37-45-18-6-3-7-19-45/h3-15,18-27,29-34,36,43-44,55,57-63,75,83H,16-17,28,35,37-42,72-73H2,1-2H3,(H2,74,84)(H,76,90)(H,77,87)(H,78,85)(H,79,88)(H,80,89)(H,81,91)(H,82,86)/t55-,57+,58-,59+,60+,61+,62-,63+/m1/s1
InChI Key
VPTPBEUWKCLZGU-OOSWLFMASA-N
Isomeric SMILES
CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H](CC2=CC3=CC=CC=C3C=C2)C(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@@H](CC8=CC=CC=C8)N
BoilingPoint
N/A
Melting Point
N/A

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide CDMOPeptide Modification ServicesPeptide Synthesis ServicesEpitope Mapping ServicesCustom Conjugation ServicePeptide Nucleic Acids SynthesisPeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers